Ind-Swift
Ind-Swift Performance
Day Range
- Low 21.9
- High 21.9
52 Week Range
- Low 6.6
- High 23.75
- Open Price0
- Previous Close22.35
- Volume2924
Start SIP in Ind-Swift
Start SIPInd-Swift Investment Rating
-
Master Rating:
-
Ind-Swift has an operating revenue of Rs. 464.82 Cr. on a trailing 12-month basis. An annual revenue de-growth of 0% needs improvement, Pre-tax margin of 6% is okay, ROE of -3% is poor and needs improvement. NULL The stock from a technical standpoint is comfortably placed above its key moving averages, around 37% and 101% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 66% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 69 which is a FAIR score but needs to improve its earnings, a RS Rating of 96 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 100 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 149 | 106 | 107 | 104 | 95 | 106 |
| Operating Expenses Qtr Cr | 130 | 98 | 89 | 93 | 90 | 96 |
| Operating Profit Qtr Cr | 18 | 8 | 18 | 11 | 5 | 10 |
| Depreciation Qtr Cr | 7 | 7 | 7 | 7 | 7 | 8 |
| Interest Qtr Cr | 15 | 14 | 15 | 15 | 15 | 14 |
| Tax Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit Qtr Cr | 2 | 53 | -1 | -11 | -15 | -5 |
Ind-Swift Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 11
- Bearish Moving Average
- ___
- 5
- 20 Day
- ₹20.95
- 50 Day
- ₹17.39
- 100 Day
- ₹14.45
- 200 Day
- ₹12.34
- 20 Day
- ₹21.32
- 50 Day
- ₹16.31
- 100 Day
- ₹12.7
- 200 Day
- ₹11.07
Ind-Swift Resistance and Support
| Resistance | |
|---|---|
| First Resistance | ₹22.35 |
| Second Resistance | ₹22.35 |
| Third Resistance | ₹22.35 |
| RSI | 71.87 |
| MFI | 58.95 |
| MACD Single Line | 2.21 |
| MACD | 2 |
| Support | |
|---|---|
| First Resistance | ₹22.35 |
| Second Resistance | ₹22.35 |
| Third Resistance | ₹22.35 |
Ind-Swift Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 20,253 | 2,025,300 | 100 |
| Week | 126,358 | 12,635,800 | 100 |
| 1 Month | 83,773 | 8,377,271 | 100 |
| 6 Month | 45,000 | 4,055,369 | 90.12 |
Ind-Swift Result Highlights
Ind-Swift Synopsis
NSE-Medical-Diversified
Ind-Swift L is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 410.96 Cr. and Equity Capital is Rs. 10.83 Cr. for the Year ended 31/03/2023. Ind-Swift Ltd. is a Public Limited Listed company incorporated on 06/06/1986 and has its registered office in the State of Chandigarh, India. Company’s Corporate Identification Number(CIN) is L24230CH1986PLC006897 and registration number is 006897.| Market Cap | 119 |
| Sales | 465 |
| Shares in Float | 2.38 |
| No of funds | 3 |
| Yield |
| Book Value | -0.04 |
| U/D Vol ratio | 1.5 |
| LTDebt / Equity | |
| Alpha | 0.45 |
| Beta | 0.5 |
Ind-Swift
| Owner Name | Jun-23 | Mar-23 | Dec-22 | Sep-22 |
|---|---|---|---|---|
| Promoters | 55.58% | 55.58% | 55.58% | 55.58% |
| Mutual Funds | ||||
| Foreign Portfolio Investors | ||||
| Financial Institutions/ Banks | ||||
| Individual Investors | 30.94% | 30.93% | 30.54% | 30.4% |
| Others | 13.48% | 13.49% | 13.88% | 14.02% |
Ind-Swift Management
| Name | Designation |
|---|---|
| Mr. S R Mehta | Executive Chairman |
| Mr. N R Munjal | Non Executive Director |
| Dr. Gopal Munjal | Managing Director & CEO |
| Dr. V R Mehta | Joint Managing Director |
| Mr. Himanshu Jain | Non Executive Director |
| Mr. Rishav Mehta | Non Executive Director |
| Mr. S P Sharma | Independent Director |
| Dr. V K Arora | Independent Director |
| Mr. S C Galhotra | Independent Director |
| Dr. Jatender Kumar Kakkar | Independent Director |
| Ms. Anoop Michra | Independent Director |
| Mr. Jagvir Singh Ahluwalia | Independent Director |
Ind-Swift Forecast
Price Estimates
Ind-Swift Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-08-10 | Quarterly Results | |
| 2023-05-30 | Audited Results | |
| 2023-02-13 | Quarterly Results | |
| 2022-11-14 | Quarterly Results | |
| 2022-08-09 | Quarterly Results |
- Company Name
- CMP
- Chg(%)
- Adani Ports
- 831
- 1.6
- Tech Mahindra
- 1292
- 1.4
- Dr Reddys Labs
- 5669
- 1.0
- Asian Paints
- 3244
- 0.9
- Bharti Airtel
- 918
- 0.8
- Company Name
- CMP
- Chg(%)
Ind-Swift FAQs
What is Share Price of Ind-Swift ?
Ind-Swift share price is ₹21 As on 21 September, 2023 | 16:47
What is the Market Cap of Ind-Swift ?
The Market Cap of Ind-Swift is ₹118.6 Cr As on 21 September, 2023 | 16:47
What is the P/E ratio of Ind-Swift ?
The P/E ratio of Ind-Swift is 2.7 As on 21 September, 2023 | 16:47
What is the PB ratio of Ind-Swift ?
The PB ratio of Ind-Swift is -0.2 As on 21 September, 2023 | 16:47